Thursday 25 April 2024
Internal Reference Number: FOI_6282
Date Request Received: 06/09/2021 00:00:00
Date Request Replied To: 11/11/2021 00:00:00
This response was sent via: By Email
Request Summary: Biologic and biosimilar products within Rheumatology
Request Category: Companies
| Question Number 1: Could provide the numbers of patients treated by the rheumatology department (for any condition) in the last 3 months with the following drugs: • Abatacept [Orencia] • Adalimumab [Humira] • Adalimumab Biosimilars • Apremilast [Otezla] • Baricitinib [Olumiant] • Certolizumab [Cimzia] • Etanercept [Enbrel] • Etanercept Biosimilars • Filgotinib [Jyseleca] • Golimumab [Simponi] • Guselkumab [Tremfya] • Infliximab [Remicade] • Infliximab Biosimilars • Ixekizumab [Taltz] • Risankizumab [Skyrizi] • Rituximab [MabThera] • Rituximab Biosimilars • Sarilumab [Kevzara] • Secukinumab [Cosentyx] • Tocilizumab [Ro Actemra] • Tofacitinib [Xeljanz] • Upadacitinib [Rinvoq] • Ustekinumab [Stelara] | |
| Answer To Question 1: • Abatacept [Orencia] 42 • Adalimumab [Humira] 29 • Adalimumab Biosimilars 214 • Apremilast [Otezla] 5 • Baricitinib [Olumiant] 66 • Certolizumab [Cimzia] 39 • Etanercept [Enbrel] 10 • Etanercept Biosimilars 115 • Filgotinib [Jyseleca] 6 • Golimumab [Simponi] 23 • Guselkumab [Tremfya] 0 • Infliximab [Remicade] 9 • Infliximab Biosimilars 25 • Ixekizumab [Taltz] 24 • Risankizumab [Skyrizi] 0 • Rituximab [MabThera] 0 • Rituximab Biosimilars 19 • Sarilumab [Kevzara] 2 • Secukinumab [Cosentyx] 18 • Tocilizumab [Ro Actemra] 43 • Tofacitinib [Xeljanz] 31 • Upadacitinib [Rinvoq] 23 • Ustekinumab [Stelara] 7 | |
| To return to the list of all the FOI requests please click here |
Our staff at Salisbury District Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.
